Oops! That page can not be found.
It looks like nothing was found at this location. Maybe try one of the links below or a search?
Kiriman Terkini
- Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
- Eisai’s Brain Health Self-Check Tool “NouKNOW” is Certified as “ME-BYO BRAND” by Kanagawa Prefecture
- Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
- Fujitsu Selected as CDP Supplier Engagement Leader
- Mazda Production and Sales Results for February 2024
Most Used Categories
- berita (18,734)
- ACN Newswire (5,998)
- Perniagaan (3,553)
- JCN Newswire (2,495)
- SeaPRwire (1,551)
- kewangan (1,388)
Arkib
Try looking in the monthly archives. 🙂